BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 17301625)

  • 1. Gender differences in health-related quality of life following ST-elevation myocardial infarction: women and men do not benefit from primary percutaneous coronary intervention to the same degree.
    Mortensen OS; Bjorner JB; Newman B; Oldenburg B; Groenvold M; Madsen JK; Andersen HR;
    Eur J Cardiovasc Prev Rehabil; 2007 Feb; 14(1):37-43. PubMed ID: 17301625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health-related quality of life one month after thrombolysis or primary PCI in patients with ST-elevation infarction. A DANAMI-2 sub-study.
    Mortensen OS; Bjorner JB; Oldenburg B; Newman B; Groenvold M; Madsen JK; Andersen HR
    Scand Cardiovasc J; 2005 Sep; 39(4):206-12. PubMed ID: 16118067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender differences in the outcome of cardiac interventions.
    Tillmanns H; Waas W; Voss R; Grempels E; Hölschermann H; Haberbosch W; Waldecker B
    Herz; 2005 Aug; 30(5):375-89. PubMed ID: 16132240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and prognostic implications of ST-segment deviations from ambulatory Holter monitoring after ST-segment elevation myocardial infarction treated with either fibrinolysis or primary percutaneous coronary intervention (a Danish Trial in Acute Myocardial Infarction-2 Substudy).
    Idorn L; Høfsten DE; Wachtell K; Mølgaard H; Egstrup K;
    Am J Cardiol; 2007 Sep; 100(6):937-43. PubMed ID: 17826373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary percutaneous coronary intervention compared with fibrinolysis for myocardial infarction in diabetes mellitus: results from the Primary Coronary Angioplasty vs Thrombolysis-2 trial.
    Timmer JR; Ottervanger JP; de Boer MJ; Boersma E; Grines CL; Westerhout CM; Simes RJ; Granger CB; Zijlstra F;
    Arch Intern Med; 2007 Jul; 167(13):1353-9. PubMed ID: 17620527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous coronary intervention in patients receiving enoxaparin or unfractionated heparin after fibrinolytic therapy for ST-segment elevation myocardial infarction in the ExTRACT-TIMI 25 trial.
    Gibson CM; Murphy SA; Montalescot G; Morrow DA; Ardissino D; Cohen M; Gulba DC; Kracoff OH; Lewis BS; Roguin N; Antman EM; Braunwald E;
    J Am Coll Cardiol; 2007 Jun; 49(23):2238-46. PubMed ID: 17560287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty: data from the CAPTIM randomized clinical trial.
    Steg PG; Bonnefoy E; Chabaud S; Lapostolle F; Dubien PY; Cristofini P; Leizorovicz A; Touboul P;
    Circulation; 2003 Dec; 108(23):2851-6. PubMed ID: 14623806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of pre-hospital combination-fibrinolysis plus conventional care with pre-hospital combination-fibrinolysis plus facilitated percutaneous coronary intervention in acute myocardial infarction.
    Thiele H; Engelmann L; Elsner K; Kappl MJ; Storch WH; Rahimi K; Hartmann A; Pfeiffer D; Kneissl GD; Schneider D; Möller T; Heberling HJ; Weise I; Schuler G;
    Eur Heart J; 2005 Oct; 26(19):1956-63. PubMed ID: 16061501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous coronary intervention-related time delay, patient's risk profile, and survival benefits of primary angioplasty vs lytic therapy in ST-segment elevation myocardial infarction.
    De Luca G; Cassetti E; Marino P
    Am J Emerg Med; 2009 Jul; 27(6):712-9. PubMed ID: 19751630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of different patterns of invasive care on quality of life outcomes in patients with non-ST elevation acute coronary syndrome: results from the GUSTO-IIb Canada-United States substudy.
    Kaul P; Armstrong PW; Fu Y; Knight JD; Clapp-Channing NE; Sutherland W; Granger CB; Mark DB;
    Can J Cardiol; 2004 Jun; 20(8):760-6. PubMed ID: 15229756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health related quality of life after percutaneous coronary intervention versus coronary artery bypass graft surgery in patients with acute coronary syndromes without ST-segment elevation. 12-month follow up.
    Szygula-Jurkiewicz B; Zembala M; Wilczek K; Wojnicz R; Polonski L
    Eur J Cardiothorac Surg; 2005 May; 27(5):882-6. PubMed ID: 15848330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic value of pre-discharge exercise testing after myocardial infarction treated with either primary PCI or fibrinolysis: a DANAMI-2 sub-study.
    Valeur N; Clemmensen P; Saunamäki K; Grande P;
    Eur Heart J; 2005 Jan; 26(2):119-27. PubMed ID: 15618067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in health-related quality of life following percutaneous coronary intervention: a longitudinal study.
    Wong MS; Chair SY
    Int J Nurs Stud; 2007 Nov; 44(8):1334-42. PubMed ID: 16982057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the predictive value of four different risk scores for outcomes of patients with ST-elevation acute myocardial infarction undergoing primary percutaneous coronary intervention.
    Lev EI; Kornowski R; Vaknin-Assa H; Porter A; Teplitsky I; Ben-Dor I; Brosh D; Fuchs S; Battler A; Assali A
    Am J Cardiol; 2008 Jul; 102(1):6-11. PubMed ID: 18572028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost and health outcome of primary percutaneous coronary intervention versus thrombolysis in acute ST-segment elevation myocardial infarction-Results of the Swedish Early Decision reperfusion Study (SWEDES) trial.
    Aasa M; Henriksson M; Dellborg M; Grip L; Herlitz J; Levin LA; Svensson L; Janzon M
    Am Heart J; 2010 Aug; 160(2):322-8. PubMed ID: 20691839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of thrombolysis followed by broad use of percutaneous coronary intervention with primary percutaneous coronary intervention for ST-segment-elevation acute myocardial infarction: data from the french registry on acute ST-elevation myocardial infarction (FAST-MI).
    Danchin N; Coste P; Ferrières J; Steg PG; Cottin Y; Blanchard D; Belle L; Ritz B; Kirkorian G; Angioi M; Sans P; Charbonnier B; Eltchaninoff H; Guéret P; Khalife K; Asseman P; Puel J; Goldstein P; Cambou JP; Simon T;
    Circulation; 2008 Jul; 118(3):268-76. PubMed ID: 18591434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [ln-hospital mortality after ST-segment elevation myocardial infarction according to reperfusion therapy].
    Prieto JC; Sanhueza C; Martínez N; Nazzal C; Corbalán R; Cavada G; Lanas F; Bartolucci J; Campos P;
    Rev Med Chil; 2008 Feb; 136(2):143-50. PubMed ID: 18483666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender differences in efficacy of primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction.
    Liu Y; Wang LF; Yang XF; Ge YG; Wang HG; Xu L; Li WM; Ni ZH; Xia K; Chi YH; Li Q; Zhang DP; Wu XQ; Sun H; Guo ZS
    Chin Med J (Engl); 2008 Dec; 121(23):2374-8. PubMed ID: 19102951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of pretreatment with clopidogrel on nonemergent percutaneous coronary intervention after fibrinolytic administration for ST-segment elevation myocardial infarction: a Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 study.
    Gibson CM; Murphy SA; Pride YB; Kirtane AJ; Aroesty JM; Stein EB; Ciaglo LN; Southard MC; Sabatine MS; Cannon CP; Braunwald E;
    Am Heart J; 2008 Jan; 155(1):133-9. PubMed ID: 18082504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombolysis followed by early revascularization: an effective reperfusion strategy in real world patients with ST-elevation myocardial infarction.
    Jaffe R; Halon DA; Karkabi B; Goldstein J; Rubinshtein R; Flugelman MY; Lewis BS
    Cardiology; 2007; 107(4):329-36. PubMed ID: 17268198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.